SCHEMBL26075146

SCHEMBL26075146

CCCCOc1cccc(-c2cc(P)c(-c3cc(C)c4cc(F)ccc4n3)cc2P)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 5/20 0.46
▸ MAPT P10636 5/20 0.40
▸ LMNA P02545 4/20 0.40
▸ ALOX12 P18054 3/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ PDE2A O00408 3/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075848 0.95 DHODH (0.43) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075147 0.91 DHODH (0.45) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075140 0.91 MEN1 (0.41) DHODHMAPTALOX12TDP1ALDH1A1
SCHEMBL26075846 0.86 PTGS2 (0.40) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075176 0.86 DHODH (0.47) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075191 0.85 DHODH (0.51) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26073784 0.85 DHODH (0.52) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075135 0.85 DHODH (0.50) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075197 0.83 DHODH (0.44) DHODHMAPTLMNAALOX12TDP1
SCHEMBL26075139 0.82 PDE10A (0.42) DHODHMAPTLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885MAPT 2689/4885LMNA 1972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback